Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

Boudewijns, Steve; Bol, Kalijn F; Schreibelt, Gerty; Westdorp, Harm; Textor, Johannes C; van Rossum, Michelle M; Scharenborg, Nicole M; de Boer, Annemiek J; van de Rakt, Mandy W M M; Pots, Jeanne M; van Oorschot, Tom G M; Duiveman-de Boer, Tjitske; Olde Nordkamp, Michel A; van Meeteren, Wilmy S E C; van der Graaf, Winette T A; Bonenkamp, Johannes J; de Wilt, Johannes H W; Aarntzen, Erik H J G; Punt, Cornelis J A; Gerritsen, Winald R; Figdor, Carl G; de Vries, I Jolanda M

Boudewijns, Steve; Bol, Kalijn F; Schreibelt, Gerty; Westdorp, Harm; Textor, Johannes C; van Rossum, Michelle M; Scharenborg, Nicole M; de Boer, Annemiek J; van de Rakt, Mandy W M M; Pots, Jeanne M; van Oorschot, Tom G M; Duiveman-de Boer, Tjitske; Olde Nordkamp, Michel A; van Meeteren, Wilmy S E C; van der Graaf, Winette T A; Bonenkamp, Johannes J; de Wilt, Johannes H W; Aarntzen, Erik H J G; Punt, Cornelis J A; Gerritsen, Winald R; Figdor, Carl G; de Vries, I Jolanda M.

Afiliación

Boudewijns S; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
Bol KF; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
Schreibelt G; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
Westdorp H; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
Textor JC; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
van Rossum MM; Department of Dermatology, Radboud University Medical Center , Nijmegen, the Netherlands.
Scharenborg NM; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
de Boer AJ; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
van de Rakt MW; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
Pots JM; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
van Oorschot TG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
Duiveman-de Boer T; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
Olde Nordkamp MA; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
van Meeteren WS; Department of Dermatology, Radboud University Medical Center , Nijmegen, the Netherlands.
van der Graaf WT; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, United Kingdom.
Bonenkamp JJ; Department of Surgical Oncology, Radboud University Medical Center , Nijmegen, the Netherlands.
de Wilt JH; Department of Surgical Oncology, Radboud University Medical Center , Nijmegen, the Netherlands.
Aarntzen EH; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Punt CJ; Department of Medical Oncology, Academic Medical Center , Amsterdam, the Netherlands.
Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center Nijmegen , Nijmegen, the Netherlands.
Figdor CG; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences , Nijmegen, the Netherlands.
de Vries IJ; Department of Medical Oncology, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands; Department of Tumor Immunology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.